Shopping Cart

Your shopping cart is currently empty

RIP2 Kinase Inhibitor 3

Name: RIP2 Kinase Inhibitor 3
Brand: TargetMol
SKU: T12728
Price: 33 USD
Availability: InStock
Rating: 5 (10 reviews)

Copy Product Info

😃Good

Catalog No. T12728Cas No. 1398053-50-3

RIP2 Kinase Inhibitor 3 is a potent and selective inhibitor of RIP2, demonstrating an IC50 of 1 nM.

RIP2 Kinase Inhibitor 3

Copy Product Info

😃Good

Purity: 99.52%

Catalog No. T12728Cas No. 1398053-50-3

RIP2 Kinase Inhibitor 3 is a potent and selective inhibitor of RIP2, demonstrating an IC50 of 1 nM.

Pack Size	Price	USA Warehouse	Global Warehouse
2 mg	$33	In Stock	In Stock
5 mg	$57	In Stock	In Stock
10 mg	$100	In Stock	In Stock
25 mg	$190	In Stock	In Stock
50 mg	$251	In Stock	In Stock
100 mg	$375	In Stock	In Stock
200 mg	$510	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:99.52%

Appearance:Solid

Color:Yellow

Resource Download

COA LCMS HNMR

Product Introduction

RIP2 Kinase Inhibitor 3 AI Summary

RIP2 Kinase Inhibitor 3 shows potent bioactivity in inhibiting multiple kinase targets, including RIPK2, human ABL2, human BRK, human FRK, human c-SRC, human EPHB4, and human TXK, as evidenced by IC50 values in various assays. It also displays selectivity for RIPK2 over human ERG and inhibits ZAK activity. Regarding cardiotoxicity, the compound exhibits a dose-dependent impact on QT interval time, Tp-e interval time, QRS interval time, and isometric contractile force in rabbit cardiac models. The compound demonstrates good oral bioavailability and pharmacokinetic properties in both Sprague-Dawley rats and Beagle dogs. Additionally, RIP2 Kinase Inhibitor 3 shows efficacy in in vivo models of peritonitis, highlighting its potential as a therapeutic agent targeting inflammatory pathways and kinase signaling..

Note: Summary generated by AI. Data source: ChEMBL

Bioactivity

Description	RIP2 Kinase Inhibitor 3 is a potent and selective inhibitor of RIP2, demonstrating an IC50 of 1 nM.
Targets&IC50	RIP2:1 nM

Chemical Properties

Molecular Weight	388.48
Formula	C₁₉H₂₄N₄O₃S
Cas No.	1398053-50-3
Smiles	COc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C
Relative Density.	1.285 g/cm3 (Predicted)

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 70 mg/mL (180.19 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.15 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	2.5741 mL	12.8707 mL	25.7414 mL	128.7068 mL
5 mM	0.5148 mL	2.5741 mL	5.1483 mL	25.7414 mL
10 mM	0.2574 mL	1.2871 mL	2.5741 mL	12.8707 mL
20 mM	0.1287 mL	0.6435 mL	1.2871 mL	6.4353 mL
50 mM	0.0515 mL	0.2574 mL	0.5148 mL	2.5741 mL
100 mM	0.0257 mL	0.1287 mL	0.2574 mL	1.2871 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc